Hypertension and urologic chronic pelvic pain syndrome: An analysis of MAPP-I data

Rosalynn R.Z. Conic,Terrie Vasilopoulos,Karthik Devulapally,Rene Przkora,Andrew Dubin,Kimberly T. Sibille,Aaron D. Mickle
DOI: https://doi.org/10.1186/s12894-024-01407-w
2024-01-29
BMC Urology
Abstract:Urologic chronic pelvic pain syndrome (UCPPS), which includes interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis (CP/CPPS), is associated with increased voiding frequency, nocturia, and chronic pelvic pain. The cause of these diseases is unknown and likely involves many different mechanisms. Dysregulated renin-angiotensin-aldosterone-system (RAAS) signaling is a potential pathologic mechanism for IC/BPS and CP/CPPS. Many angiotensin receptor downstream signaling factors, including oxidative stress, fibrosis, mast cell recruitment, and increased inflammatory mediators, are present in the bladders of IC/BPS patients and prostates of CP/CPPS patients. Therefore, we aimed to test the hypothesis that UCPPS patients have dysregulated angiotensin signaling, resulting in increased hypertension compared to controls. Secondly, we evaluated symptom severity in patients with and without hypertension and antihypertensive medication use.
urology & nephrology
What problem does this paper attempt to address?